Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study by Camilla S. Graham, Brianna Bisson, Jessica Shore, Emily Pardy, Frank Salisbury, Lisa Lancaster, Tejaswini Kulkarni

Get full text

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Poin... by Steven D. Nathan, MD, Juergen Behr, MD, Vincent Cottin, MD, Lisa Lancaster, MD, Peter Smith, PharmD, CQ Deng, PhD, Natalie Breytenbach, PharmD, Heidi Bell, MD, Leigh Peterson, PhD, Kevin R. Flaherty, MD

Get full text

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

Get full text

Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study by Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A. Wuyts, R. Gisli Jenkins, Mary Beth Scholand, Michael Kreuter, Claudia Valenzuela, Christopher J. Ryerson, Jonathan Goldin, Grace Hyun J. Kim, Marzena Jurek, Martin Decaris, Annie Clark, Scott M. Turner, Chris N. Barnes, Hardean E. Achneck, Gregory P. Cosgrove, Éric A. Lefebvre, Kevin R. Flaherty

Get full text